In the last years, change in multiple sclerosis (MS) therapeutic scenario has highlighted the need for an improved doctor-patient communication in advance of treatment initiation in order to allow patient's empowerment in the decision-making process. Aims The aims of our project were to review the strategies used by Italian MS specialists to inform patients about treatment options and to design a multicentre shared document that homogenizes the information about disease-modifying treatment (DMTs) and the procedure of taking informed consent in clinical practice. Results The new resource, obtained by consensus among 31 neurologists from 27 MS Centres in Italy with the supervision of a medico-legal advisor, received the aegis of Italian Neurological Society (SIN) and constitutes a step toward a standardized decision process around DMTs in MS.
Informing MS patients on treatment options: a consensus on the process of consent taking / Tortorella, C; Solaro, C; Annovazzi, P; Boffa, L; Buscarinu, M C; Buttari, F; Calabrese, M; Cavalla, P; Cocco, E; Cordioli, C; De Luca, G; Di Filippo, M; Fantozzi, R; Ferraro, D; Gajofatto, A; Gallo, A; Lanzillo, R; Laroni, A; Fermo, S Lo; Malucchi, S; Maniscalco, G T; Moccia, M; Nociti, V; Paolicelli, D; Pesci, I; Prosperini, L; Ragonese, P; Tomassini, V; Clerici, V L A Torri; Rodegher, M; Gherardi, M; Gasperini, C. - In: NEUROLOGICAL SCIENCES. - ISSN 1590-1874. - 41:8(2020), pp. 2249-2253. [10.1007/s10072-020-04339-z]
Informing MS patients on treatment options: a consensus on the process of consent taking
Di Filippo, M;Fantozzi, R;Ferraro, D;Paolicelli, D;Tomassini, V;
2020
Abstract
In the last years, change in multiple sclerosis (MS) therapeutic scenario has highlighted the need for an improved doctor-patient communication in advance of treatment initiation in order to allow patient's empowerment in the decision-making process. Aims The aims of our project were to review the strategies used by Italian MS specialists to inform patients about treatment options and to design a multicentre shared document that homogenizes the information about disease-modifying treatment (DMTs) and the procedure of taking informed consent in clinical practice. Results The new resource, obtained by consensus among 31 neurologists from 27 MS Centres in Italy with the supervision of a medico-legal advisor, received the aegis of Italian Neurological Society (SIN) and constitutes a step toward a standardized decision process around DMTs in MS.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Tortorella_2020.pdf
Accesso riservato
Dimensione
186.67 kB
Formato
Adobe PDF
|
186.67 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
